The Penlon Prima 320 Advance anaesthetic machine is now available with Masimo® anaesthetic gas monitoring option.
Penlon Limited announces the immediate launch of the updated Penlon Prima 320 Advance anaesthetic machine with the new Masimo® anaesthetic gas monitoring option. This latest update to Penlon’s range of cost-effective anaesthetic machines enables clinicians to accurately measure CO2, N2O and anaesthetic agents without the need for a separate monitor.
The optional Masimo IRMA™ Mainstream multi-gas technology in the Prima 320 Advance provides real-time, accurate and continuous measurement of inspired and expired gas concentrations and respiratory rate. This new anaesthetic gas monitoring option allows the Prima 320 Advance to accurately measure CO2, N2O, and anaesthetic agents (Halothane, Enflurane, Isoflurane, Sevoflurane, and Desflurane) with automatic agent identification.
The Prima 320 Advance and other products from Penlon’s portfolio will be on display at MEDICA (Düsseldorf, Germany) and Arab Health (Dubai, UAE) in the coming months.
Penlon is a world-class British medical device company established in Oxford in 1943. Penlon develops, manufactures and exports anaesthesia and other medical products to over ninety countries worldwide. In 2020 Penlon responded to the UK Government’s call-to-arms producing 11,683 ventilators in just three months in the fight against COVID-19.
